Lensche H, Diet F, von Scheidt W, Uberfuhr P, Reichart B, Erdmann E, Böhm M
Klinik III für Innnere Medizin, Universität zu Köln, Cologne, Germany.
Res Exp Med (Berl). 1994;194(2):81-96. doi: 10.1007/BF02576369.
In mononuclear leukocytes (MNL) of renal transplant recipients treated with cyclosporine A and prednisone, an increase of basal cAMP generation has been observed. In order to characterize the mechanisms underlying changes of cAMP generation in patients who were treated with immunosuppressives following heart transplantation, we investigated the beta-adrenoceptor--G protein--adenylate cyclase signal transduction cascade in heart transplant recipients and for comparison in renal transplant recipients as well as controls. Basal cAMP formation in MNL was elevated in heart transplant recipients by 272% and in renal transplant recipients by 148% compared to controls. Following beta-adrenoceptor stimulation with isoprenaline, cAMP formation in MNL of heart transplant recipients was similar to the controls, but was enhanced in renal transplant recipients to 138%. Investigation of beta-adrenoceptor density on MNL as a possible cause for increased cAMP formation revealed similar receptor numbers in controls and in cardiac or renal transplant recipients. Furthermore, the increase of the beta-adrenoceptor density on MNL, which is observed following infusion of isoprenaline, was similar in controls and heart transplant recipients. The amount of pertussis- and cholera toxin substrates was the same in heart transplant recipients as in controls. In contrast, MNL of renal transplant recipients showed a marked increase of Gs alpha by 45% and a smaller albeit significant increase of Gi alpha by 15%, as judged by cholera toxin and pertussis toxin labeling, respectively. Investigation of inotropic parameters by echocardiography under control conditions and during the infusion of increasing concentrations of isoprenaline revealed no difference in the basal contractility and the inotropic response to beta-adrenergic stimulation in controls and heart transplant recipients. It is concluded that changes of G-protein expression are involved in the increase of the cAMP-generation in MNL of heart transplant recipients. These alterations in MNL cannot be taken as a model of cellular function in the transplanted heart, but it is reasonable to suggest that elevations of cAMP formation in MNL may contribute to the immunosuppressive effects of the treatment with cyclosporine A or corticosteroids, the mechanism of which could be an alteration of Gs alpha or the catalyst in renal transplant recipients and the catalyst in heart transplant recipients which occurs without any changes of beta-adrenoceptors.
在用环孢素A和泼尼松治疗的肾移植受者的单核白细胞(MNL)中,已观察到基础cAMP生成增加。为了阐明心脏移植后接受免疫抑制剂治疗的患者中cAMP生成变化的潜在机制,我们研究了心脏移植受者中的β-肾上腺素能受体-G蛋白-腺苷酸环化酶信号转导级联反应,并与肾移植受者及对照组进行比较。与对照组相比,心脏移植受者MNL中的基础cAMP生成增加了272%,肾移植受者增加了148%。在用异丙肾上腺素刺激β-肾上腺素能受体后,心脏移植受者MNL中的cAMP生成与对照组相似,但肾移植受者中增加到138%。对MNL上β-肾上腺素能受体密度作为cAMP生成增加的可能原因进行研究发现,对照组与心脏或肾移植受者中的受体数量相似。此外,在输注异丙肾上腺素后观察到的MNL上β-肾上腺素能受体密度的增加,在对照组和心脏移植受者中相似。心脏移植受者中百日咳毒素和霍乱毒素底物的量与对照组相同。相反,通过霍乱毒素和百日咳毒素标记判断,肾移植受者的MNL中Gsα显著增加45%,Giα虽增加幅度较小但也有显著增加,为15%。在对照条件下以及在输注浓度递增的异丙肾上腺素期间,通过超声心动图对变力参数进行研究发现,对照组和心脏移植受者在基础收缩力和对β-肾上腺素能刺激的变力反应方面没有差异。结论是,G蛋白表达的变化参与了心脏移植受者MNL中cAMP生成的增加。MNL中的这些改变不能被视为移植心脏中细胞功能的模型,但有理由认为MNL中cAMP生成的升高可能有助于环孢素A或皮质类固醇治疗的免疫抑制作用,其机制可能是肾移植受者中Gsα或催化因子以及心脏移植受者中催化因子的改变,而β-肾上腺素能受体没有任何变化。